biphasic insulin aspart 30
BIASP-3963
Approved small_molecule completed
Quick answer
biphasic insulin aspart 30 for Diabetes is a Approved program (small_molecule) at Novo Nordisk A/S with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Diabetes
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed